NCT05420948 2026-04-09
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
University of Chicago
Phase 2 Suspended
University of Chicago
Medical University of South Carolina
Dana-Farber Cancer Institute
Stanford University
Henry Ford Health System
Sunnybrook Health Sciences Centre
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Charite University, Berlin, Germany